288
Participants
Start Date
February 1, 2018
Primary Completion Date
July 29, 2021
Study Completion Date
December 24, 2021
Rivaroxaban(Xarelto, BAY 59-7939)
The dosage and the anticoagulation duration is decided by investigators. As list in product information, the PE treatment dosage of rivaroxaban is 15mg bid for first 21 days and then 20mg qd. If CrCl is 30-49 ml/min and bleeding risk is over VTE recurrence risk, 20mg qd can be replaced with 15mg qd.
Many locations, Multiple Locations
Lead Sponsor
Janssen Research & Development, LLC
INDUSTRY
Bayer
INDUSTRY